Showing results (11-20 of 184) with videos related to
Sort By:
Pageof 19
British Journal of Pharmacology|April 3, 1999
Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioningJ Imagawa, D M Yellon, G F BaxterJournal of Molecular and Cellular Cardiology|July 1, 1997
Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbitJ i Imagawa, G F Baxter, D M YellonBasic Research in Cardiology|June 1, 1997
Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardiumG F Baxter, F M Goma, D M YellonBritish Journal of Pharmacology|May 12, 2000
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injuryM M Mocanu, G F Baxter, D M YellonBritish Journal of Pharmacology|May 1, 1995
Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardiumG F Baxter, F M Goma, D M YellonJournal of Molecular and Cellular Cardiology|July 1, 1997
Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivoG F Baxter, M M Mocanu, D M YellonCardiovascular Research|July 1, 1994
Ischaemic preconditioning protects hypertrophied myocardiumM E Speechly-Dick, G F Baxter, D M YellonJournal of the American College of Cardiology|April 30, 1998
Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned stateA Dana, G F Baxter, J M Walker, et al.Cardiovascular Drugs and Therapy|June 18, 1999
Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanismM M Mocanu, S Gadgil, D M Yellon, et al.Circulation|December 1, 1994
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioningG F Baxter, M S Marber, V C Patel, et al.Pageof 19